https://www.ncbi.nlm.nih.gov/pubmed/29713608 NAFLD

Pediatr Gastroenterol Hepatol Nutr. 2018 Apr;21(2):111-117. doi: 10.5223/pghn.2018.21.2.111. Epub 2018 Apr 13. Battal F1, Türkön H2, Aylanç N3, Aylanç H1, Yıldırım Ş1, Kaymaz N

Abstract

PURPOSE:
The prevalence of obesity has significantly increased among children and adolescents worldwide and is becoming an important health care problem in parallel with the increased prevalence of obesity pediatric non-alcoholic fatty liver disease. Betatrophin is a newly define hormone that is commonly secreted by liver and plays role in glucose tolerance. This study aimed to investigate the relationship between serum betatrophin levels and non-alcoholic fatty liver disease in obese children.

METHODS:
The study included 40 obese children with a body mass index (BMI) above 95th centile, and 35 non-obese subjects with a BMI 3-85th centile, whose age and gender were similar to those of the patient group. For the evaluation of metabolic parameters fasting serum glucose, insulin, alanine aminotransferase, aspartate aminotransferase, lipid profile and serum betatrophin levels were measured. Total cholesterol: high-density lipoprotein cholesterol and low-density lipoprotein cholesterol: high-density lipoprotein cholesterol ratios were calculated as "atherogenic indices."

RESULTS:
Serum betatrophin levels of the obese subjects were similar to that of non-obese subjects (p=0.90). Betatrophin levels were not correlated with the metabolic parameters.

CONCLUSION:
In the present study, levels of betatrophin are not different between obese and insulin resistant childrenand non-obese subjects, and they are not correlated with atherogenic indices. To elucidate the exact role of betatrophin in obesity, further studies are required to identify the betatrophin receptor and/or other possible cofactors.